XML 126 R43.htm IDEA: XBRL DOCUMENT
v3.8.0.1

SHARE-BASED PAYMENTS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Schedule of share-based compensation, stock options, activity | The summary of the Company’s stock options at December 31, 2017, 2016 and 2015, respectively, and the changes for the fiscal periods ending on those dates are presented below:
| Range of Exercise Prices $ |  | Weighted Average Exercise Price $ |  | Number of Options
Balance, January 1, 2015 | 7.60 - 44.22 |  | 11.66 |  | 905,413
Granted | 2.55 - 18.55 |  | 6.02 |  | 2,176,330
Exercised | 2.55 - 4.48 |  | 3.78 |  | (48,802)
Forfeited | 4.44 - 29.71 |  | 7.29 |  | (574,486)
Expired | 7.47 - 32.10 |  | 7.42 |  | (335,558)
Balance, December 31, 2015 | 2.55 - 32.10 |  | 6.54 |  | 2,122,897
Granted | 2.12 - 2.22 |  | 2.13 |  | 449,537
Exercised | 2.12 |  | 2.12 |  | (8,369)
Forfeited | 2.12 - 18.99 |  | 5.52 |  | (317,960)
Expired | 2.95 - 32.03 |  | 8.03 |  | (200,962)
Balance, December 31, 2016 | 2.12 - 15.61 |  | 5.69 |  | 2,045,143
Granted | 1.77 - 2.35 |  | 2.34 |  | 738,893
Exercised | — |  | — |  | —
Forfeited | 2.12 - 11.94 |  | 2.93 |  | (316,289)
Expired | 4.48 - 12.55 |  | 8.42 |  | (438,900)
Balance, December 31, 2017 | 1.77 - 15.61 |  | 4.48 |  | 2,028,847
Schedule of share-based compensation, shares authorized under stock option plans, by exercise price range | As of December 31, 2017, the outstanding stock options denominated in Cdn$ were as follows:
| Options outstanding |  | Options exercisable
Exercise price | Quantity |  | Weighted average price |  | Weighted average remaining contractual life |  | Intrinsic Value |  | Quantity |  | Weighted average price |  | Weighted average remaining contractual life |  | Intrinsic Value
$5.00 to $9.99 | 393,100 |  |  | 8.26 |  |  | 1.17 |  | — |  |  | 393,100 |  |  | 8.26 |  |  | 1.17 |  | — |
| 393,100 |  |  |  |  |  |  | $ | — |  |  | 393,100 |  |  |  |  |  |  | $ | — |
As of December 31, 2017, the outstanding stock options denominated in USD$ were as follows:
| Options outstanding |  | Options exercisable
Exercise price | Quantity |  | Weighted average price |  | Weighted average remaining contractual life |  | Intrinsic Value |  | Quantity |  | Weighted average price |  | Weighted average remaining contractual life |  | Intrinsic Value
$0.00 to $4.99 | 1,276,456 |  |  | $ | 2.97 |  |  | 4.49 |  | $ | — |  |  | 911,276 |  |  | $ | 3.24 |  |  | 4.73 |  | $ | — |
$5.00 to $9.99 | 255,762 |  |  | 6.00 |  |  | 4.10 |  | — |  |  | 255,762 |  |  | 6.00 |  |  | 4.10 |  | — |
$10.00 to $14.99 | 90,779 |  |  | 10.69 |  |  | 0.50 |  | — |  |  | 90,779 |  |  | 10.69 |  |  | 0.50 |  | — |
$15.00 to $19.99 | 12,750 |  |  | $ | 15.61 |  |  | 3.03 |  | — |  |  | 12,750 |  |  | $ | 15.61 |  |  | 3.03 |  | — |
| 1,635,747 |  |  |  |  |  |  | $ | — |  |  | 1,270,567 |  |  |  |  |  |  | $ | — |
Schedule of compensation costs for share-based payment arrangements | The share-based compensation recorded during the years ended months ended December 31, 2017, 2016 and 2015 is as follows:
| Years ended
| December 31,
| 2017 |  | 2016 |  | 2015
Share-based compensation (1)(2) | $ | 3,525 |  |  | $ | 2,657 |  |  | $ | 1,099 |
Replacement of options from business combinations and asset acquisitions (3) | — |  |  | — |  |  | 3,681 |
Value of stock options and RSUs granted | $ | 3,525 |  |  | $ | 2,657 |  |  | $ | 4,780 |
(1) | The fair value of the options granted under the Compensation Plan for the years ended December 31, 2017, 2016 and 2015, was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted-average assumptions:
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions | The following weighted average assumptions were used for the Black-Scholes option pricing model to calculate the $0.39 million of fair value for the 2,515,625 warrants at December 31, 2017.
Risk-free rate | 1.76%
Expected life | 1.2 years
Expected volatility | 63.7%*
Expected dividend yield | 0%
* Expected volatility is measured based on the Company’s historical share price volatility over the expected life of the warrants. The following weighted average assumptions were used for the Black-Scholes option pricing model to calculate the $2.09 million of fair value for the 2,515,625 warrants issued in connection with the public offering in March 2016.
Risk-free rate | 1.15%
Expected life | 3.0 years
Expected volatility | 106.0%*
Expected dividend yield | 0%
* Expected volatility is measured based on the Company’s historical share price volatility over the expected life of the warrants. The following weighted average assumptions were used for the Black-Scholes option pricing model to calculate the $3.17 million of fair value for the 4,168,750 warrants issued in connection with the public offering in September 2016.
Risk-free rate | 1.2%
Expected life | 5.0 years
Expected volatility | 145.2%*
Expected dividend yield | 0%
* Expected volatility is measured based on the Company’s historical share price volatility over the expected life of the warrants.
| 2017 |  | 2016 |  | 2015
Risk-free interest rate | 1.93% |  |  | 1.03% - 1.43% |  |  | 0.87 | %
Expected life | 5.0 years |  |  | 5.0 years |  |  | 5.0 years |
Expected volatility | 63.0%* |  |  | 64.7% -74.8%* |  |  | 75.1%* |
Expected dividend yield | 0 | % |  | 0 | % |  | 0 | %
Weighted-average expected life of option | 5.00 |  |  | 5.00 |  |  | 4.99 |
Weighted-average grant date fair value | $1.20 |  |  | $1.22 - $1.23 |  |  | 2.64 |
* Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the options.
Risk-free interest rate | 0.0% to 2.35% |
Expected life | 0.05 years to 10 years |
Expected volatility | 18.47 to 93.31%* |
Expected dividend yield | 0 | %
Weighted-average expected life of option | 4.52 |
Weighted-average grant date fair value | $1.89
* Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the options.
Schedule of share-based compensation, restricted stock and restricted stock units activity | A summary of the status and activity of non-vested stock options at December 31, 2017 is as follows:
| Number of shares |  | Weighted Average Grant- Date Fair Value
Non-vested January 1, 2015 | 139,600 |  |  | $ | 5.27 |
Granted | 2,176,330 |  |  | 1.93 |
Vested | (2,119,803 | ) |  | 2.00 |
Forfeited | (18,429 | ) |  | 5.17 |
Non-vested December 31, 2015 | 177,698 |  |  | 3.44 |
Granted | 449,537 |  |  | 1.29 |
Vested | (331,482 | ) |  | 2.26 |
Forfeited | (68,575 | ) |  | 1.56 |
Non-vested December 31, 2016 | 227,178 |  |  | 1.48 |
Granted | 738,893 |  |  | 1.18 |
Vested | (486,386 | ) |  | 1.30 |
Forfeited | (114,505 | ) |  | 1.22 |
Non-vested December 31, 2017 | 365,180 |  |  | $ | 1.20 |
A summary of the status and activity of non-vested RSUs at December 31, 2017 is as follows:
| Number of shares |  | Weighted Average Grant- Date Fair Value
Non-vested January 1, 2015 | — |  |  | $ | — |
Granted | 282,716 |  |  | 4.05 |
Vested | — |  |  | — |
Forfeited | (9,850 | ) |  | 4.68 |
Non-vested December 31, 2015 | 272,866 |  |  | 4.03 |
Granted | 1,205,336 |  |  | 2.14 |
Vested | (138,608 | ) |  | 4.65 |
Forfeited | (9,125 | ) |  | 5.39 |
Non-vested December 31, 2016 | 1,330,469 |  |  | 2.37 |
Granted | 1,390,705 |  |  | 2.09 |
Vested | (752,580 | ) |  | 2.35 |
Forfeited | (59,118 | ) |  | 2.29 |
Non-vested December 31, 2017 | 1,909,477 |  |  | $ | 2.17 |

X
- Definition Schedule of Compensation Costs for Share-based Payment Arrangements [Table Text Block] + References No definition available. + Details
Name: | efr_ScheduleOfCompensationCostsForSharebasedPaymentArrangementsTableTextBlock
Namespace Prefix: | efr_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration